Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
KC’s ‘vacation ice cream parlor’ floats into City Market; scooping two passions into one sweet escape
The connection between two of Lucas Thompson’s businesses — KC Soda Co. and the freshly opened Fountain City Scoops and Floats — provides the perfect opportunity to blend soda and ice cream, he said. “I’m not sure there’s another float place in the region,” Thompson said of the new shop in the City Market. “As…
‘Neon Alley’ turning on 40 historic KC signs at Pennway Point, lighting the way to new entertainment district
The planned Pennway Point entertainment district near the Crossroads and Union Station soon will be awash in the glow of neon history, said Nick Vedros. “What’s more Kansas City than to have all these great signs that were once part of our city’s historical fabric all in one spot?” said Vedros, teasing the future Lumi…
This KC sausage maker serves one of America’s best vegan hot dogs; the PETA-approved menu item wasn’t an afterthought or gimmick, its owners say
Wiener Kitchen has always been a community-driven venture, said Jessica Rush, which includes providing options for all members of the community — meat eater or not. “We started at a farmers’ market, and I felt really strongly about having a vegetarian and vegan option. A lot of people go to the farmers’ market because they…
Don’t sleep on ‘Barbie’, KC theater owner warns as Barbenheimer blockbuster arrives
‘Barbenheimer’ could bring best movie-going weekend in nearly a decade; How KC theaters are getting dolled up for the blockbuster Local theaters are expecting a blockbuster weekend, thanks to a highly anticipated and unlikely double feature opening Thursday. Dubbed “Barbenheimer,” the high-profile films “Barbie” — a fictionalized focus on the doll-turned-fashion icon — and “Oppenheimer”…